Skip to Main Content

Author Details

Kurt W Kohn
Center for Cancer Research, National Cancer Institute
1957
252
93
PMIDPaper TitleJournal TitlePublished Year
33086069SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.Cell Rep2020
33086069SCLC-CellMiner: A Resource for Small Cell Lung Cancer Cell Line Genomics and Pharmacology Based on Genomic Signatures.Cell Rep2020
30553813CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.iScience2018
30553813CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines.iScience2018
27923837The NCI-60 Methylome and Its Integration into CellMiner.Cancer Res2017
27923837The NCI-60 Methylome and Its Integration into CellMiner.Cancer Res2017
25213708Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.Hum Genet2015
26020938Predicted Role of NAD Utilization in the Control of Circadian Rhythms during DNA Damage Response.PLoS Comput Biol2015
25213708Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancer.Hum Genet2015
26020938Predicted Role of NAD Utilization in the Control of Circadian Rhythms during DNA Damage Response.PLoS Comput Biol2015
24940735Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype.PLoS One2014
25032700NCI-60 whole exome sequencing and pharmacological CellMiner analyses.PLoS One2014
24940735Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype.PLoS One2014
25032700NCI-60 whole exome sequencing and pharmacological CellMiner analyses.PLoS One2014
23547033PathVisio-Faceted Search: an exploration tool for multi-dimensional navigation of large pathways.Bioinformatics2013
24360018SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism.Genome Integr2013
23786772Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.Cancer Res2013
23547033PathVisio-Faceted Search: an exploration tool for multi-dimensional navigation of large pathways.Bioinformatics2013
24360018SIRT1/PARP1 crosstalk: connecting DNA damage and metabolism.Genome Integr2013
23786772Transcription poisoning by Topoisomerase I is controlled by gene length, splice sites, and miR-142-3p.Cancer Res2013
22199389PathVisio-Validator: a rule-based validation plugin for graphical pathway notations.Bioinformatics2012
22753480Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response.Proc Natl Acad Sci U S A2012
22848369Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.PLoS One2012
22802077CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.Cancer Res2012
22291933Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines.PLoS One2012
22570691Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes.PLoS One2012
22199389PathVisio-Validator: a rule-based validation plugin for graphical pathway notations.Bioinformatics2012
22802077CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.Cancer Res2012
22753480Heat shock protein 90α (HSP90α), a substrate and chaperone of DNA-PK necessary for the apoptotic response.Proc Natl Acad Sci U S A2012
22848369Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples.PLoS One2012
22570691Gene expression profiles of the NCI-60 human tumor cell lines define molecular interaction networks governing cell migration processes.PLoS One2012
22291933Functional categories associated with clusters of genes that are co-expressed across the NCI-60 cancer cell lines.PLoS One2012
21636591PathVisio-MIM: PathVisio plugin for creating and editing Molecular Interaction Maps (MIMs).Bioinformatics2011
21586134A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method.BMC Bioinformatics2011
21636591PathVisio-MIM: PathVisio plugin for creating and editing Molecular Interaction Maps (MIMs).Bioinformatics2011
21586134A formal MIM specification and tools for the common exchange of MIM diagrams: an XML-Based format, an API, and a validation method.BMC Bioinformatics2011
20174603Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.PLoS Comput Biol2010
20817775Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.Cancer Res2010
20442302mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.Mol Cancer Ther2010
20174603Predicted functions of MdmX in fine-tuning the response of p53 to DNA damage.PLoS Comput Biol2010
20817775Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.Cancer Res2010
20442302mRNA and microRNA expression profiles of the NCI-60 integrated with drug activities.Mol Cancer Ther2010
18955500Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.Mol Cell Biol2009
19557000Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.EMBO Rep2009
19556879Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis.Cell Cycle2009
19668183The Systems Biology Graphical Notation.Nat Biotechnol2009
18955500Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways.Mol Cell Biol2009
19668183The Systems Biology Graphical Notation.Nat Biotechnol2009
19557000Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.EMBO Rep2009
19556879Network architecture of signaling from uncoupled helicase-polymerase to cell cycle checkpoints and trans-lesion DNA synthesis.Cell Cycle2009
  • 1 - 50 of 504

Recommended Authors

Faculty of Pharmacy, University of Seville
Career Start Year 2010
Number of shared co-authors 1
The University of Sheffield
Career Start Year 1998
Number of shared co-authors 1
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 1993
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 1992
Number of shared co-authors 6
Division of Cancer and Ovarian Cancer Action Research Centre, Imperial College London
Career Start Year 1990
Number of shared co-authors 0
University of Calgary, 0 Hospital Drive NW
Career Start Year 1989
Number of shared co-authors 0
University of California los angeles
Career Start Year 1988
Number of shared co-authors 0
Mission Therapeutics Ltd. Glenn Berge Building
Career Start Year 1987
Number of shared co-authors 1
University of South Alabama
Career Start Year 1987
Number of shared co-authors 0
GE Research Center
Career Start Year 1987
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 2
New York University School of Medicine
Career Start Year 1985
Number of shared co-authors 2
UPMC-Hillman Cancer Center, University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 0
University of Chicago
Career Start Year 1981
Number of shared co-authors 1
Norwich Medical School, University of East Anglia
Career Start Year 1978
Number of shared co-authors 2
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 2
Massachusetts Institute of Technology
Career Start Year 1977
Number of shared co-authors 0
University of Puerto Rico
Career Start Year 1977
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 0
Western University, Lawson Health Research Institute
Career Start Year 1975
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1974
Number of shared co-authors 6
Moores Cancer Center and Department of Medicine, University of California
Career Start Year 1974
Number of shared co-authors 1
Center for Devices and Radiological Health
Career Start Year 1973
Number of shared co-authors 1
National Institute of Environmental Health Sciences
Career Start Year 1973
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1972
Number of shared co-authors 1
University Hospital Essen
Career Start Year 1972
Number of shared co-authors 0
PHusis Therapeutics Inc.
Career Start Year 1970
Number of shared co-authors 2
Stanford University School of Medicine
Career Start Year 1968
Number of shared co-authors 1
Simons Center for Systems Biology, Institute for Advanced Study
Career Start Year 1967
Number of shared co-authors 3

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 107
The University of Texas MD Anderson Cancer Center
Co-authored papers 27
National Cancer Institute, Center for Cancer Research
Co-authored papers 18
Center for Cancer Research, National Cancer Institute
Co-authored papers 15
Harvard Medical School
Co-authored papers 12
Co-authored papers 10
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 7
Co-authored papers 6
Gustave Roussy Cancer Center, INSERM U1170
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
Peking University Cancer Hospital
Co-authored papers 3
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 3
Universidade Federal De Mato Grosso Do Sul
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
National Cancer Institute, National Institutes of Health
Co-authored papers 3
Institute of Biomedical Engineering (IBME), University of Oxford
Co-authored papers 3
University of Oxford
Co-authored papers 2
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Oncology R&D
Co-authored papers 2
Salk Institute for Biological Studies
Co-authored papers 2
Co-authored papers 2
Inc., Frederick National Laboratory for Cancer Research
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
and Blood Institute, National Institutes of Health
Co-authored papers 2
USA The Jackson Laboratory Cancer Center
Co-authored papers 2
Broad Institute of MIT and Harvard
Co-authored papers 2
Co-authored papers 2